secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001641172-25-022580
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis Q2 revenue surges 95% to $8.8M; net loss narrows to $3.8M
---------------------------------------------------------------------

- Revenue $8.8M (+95% YoY, +18% seq); system revenue $3.0M (vs $0.2M), recurring $5.8M (+35% YoY).
- Net loss $3.8M vs $5.8M; adjusted net loss $1.3M vs $3.3M; gross margin 52%.
- Cash $7.0M at June 30; July $12.5M financing closed; pro forma cash $18.8M, no debt.
- Guidance: double-digit FY2025 revenue growth; Q4 recurring ~$7M; system $2-3M/quarter.
- FDA clearance for MAGiC Sweep catheter; initial sales in Q2; further approvals expected near-term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/0001641172-25-022580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer